BioGaia AB (publ) (FRA:BGLA)

BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of EUR 1.02 billion. The enterprise value is 942.44 million.

Market Cap	1.02B
Enterprise Value	942.44M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	98.50M
Shares Outstanding	n/a
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.89%
Owned by Institutions (%)	40.39%
Float	71.93M

Valuation Ratios

The trailing PE ratio is 33.09 and the forward PE ratio is 25.87.

PE Ratio	33.09
Forward PE	25.87
PS Ratio	7.16
PB Ratio	8.38
P/TBV Ratio	9.44
P/FCF Ratio	36.34
P/OCF Ratio	35.92
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.11, with an EV/FCF ratio of 33.66.

EV / Earnings	30.65
EV / Sales	6.54
EV / EBITDA	21.11
EV / EBIT	22.27
EV / FCF	33.66

Financial Position

The company has a current ratio of 6.12

Current Ratio	6.12
Quick Ratio	4.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	74.62

Financial Efficiency

Return on equity (ROE) is 21.91% and return on invested capital (ROIC) is 71.21%.

Return on Equity (ROE)	21.91%
Return on Assets (ROA)	15.56%
Return on Invested Capital (ROIC)	71.21%
Return on Capital Employed (ROCE)	32.31%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	587,319
Profits Per Employee	127,059
Employee Count	242
Asset Turnover	0.85
Inventory Turnover	n/a

Taxes

In the past 12 months, BioGaia AB has paid 8.17 million in taxes.

Income Tax	8.17M
Effective Tax Rate	21.00%

Stock Price Statistics

The stock price has decreased by -16.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.88%
50-Day Moving Average	9.83
200-Day Moving Average	9.39
Relative Strength Index (RSI)	47.68
Average Volume (20 Days)	32

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of EUR 142.13 million and earned 30.75 million in profits. Earnings per share was 0.30.

Revenue	142.13M
Gross Profit	104.28M
Operating Income	41.76M
Pretax Income	38.92M
Net Income	30.75M
EBITDA	44.04M
EBIT	41.76M
Earnings Per Share (EPS)	0.30

Balance Sheet

The company has 74.04 million in cash and n/a in debt, with a net cash position of 74.04 million.

Cash & Cash Equivalents	74.04M
Total Debt	n/a
Net Cash	74.04M
Net Cash Per Share	n/a
Equity (Book Value)	121.44M
Book Value Per Share	1.20
Working Capital	94.24M

Cash Flow

In the last 12 months, operating cash flow was 28.33 million and capital expenditures -325,628, giving a free cash flow of 28.00 million.

Operating Cash Flow	28.33M
Capital Expenditures	-325,628
Free Cash Flow	28.00M
FCF Per Share	n/a

Margins

Gross margin is 73.37%, with operating and profit margins of 29.38% and 21.63%.

Gross Margin	73.37%
Operating Margin	29.38%
Pretax Margin	27.38%
Profit Margin	21.63%
EBITDA Margin	30.99%
EBIT Margin	29.38%
FCF Margin	19.70%

Dividends & Yields

This stock pays an annual dividend of 0.63, which amounts to a dividend yield of 6.60%.

Dividend Per Share	0.63
Dividend Yield	6.60%
Dividend Growth (YoY)	6.92%
Years of Dividend Growth	2
Payout Ratio	209.76%
Buyback Yield	-0.09%
Shareholder Yield	6.51%
Earnings Yield	3.02%
FCF Yield	2.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5